SMAD2 and neoplasm: We observed phosphorylated SMAD2 (S465/467) and phosphorylated p38 (T180/Y182) at the tumor-liver interface of RHGP lesions, but not at the tumor-liver interface of DHGP lesions (Supplementary Fig. 3).